|4Jul 17, 5:18 PM ET

Chell Jeffrey W. 4

4 · Actinium Pharmaceuticals, Inc. · Filed Jul 17, 2018

Insider Transaction Report

Form 4
Period: 2018-07-13
Transactions
  • Award

    Options to purchase common stock

    2018-07-13$0.78/sh+75,000$58,71875,000 total
    Exercise: $0.78Exp: 2028-07-13Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary